+499.5%
MRNA vs ROIV
+177.7%
+321.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ROIV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.5% | -3.7% | -3.1% |
| 7D | +5.5% | +0.6% | +4.8% | +5.0% |
| 30D | +158.7% | +1.0% | +157.8% | +156.5% |
| 3M | +182.1% | +18.3% | +163.8% | +156.6% |
| 6M | +151.8% | +18.3% | +133.5% | +127.6% |
| YTD | +393.6% | +61.0% | +332.6% | +295.8% |
| 1Y | +499.5% | +177.9% | +321.6% | +254.1% |
| All | +499.5% | +177.7% | +321.8% | +254.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ROIV.
Daily Out/Under-Performance
Portfolio return minus ROIV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ROIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ROIV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling